New hope for clearer eyes: study tests redness relief for glaucoma patients
NCT ID NCT04007276
Summary
This study is testing whether Lumify eye drops can safely reduce eye redness in people with glaucoma who already use similar glaucoma medications. Researchers will measure redness, eye pressure, and eyelid position in 60 participants. The goal is to see if this FDA-approved redness reliever works well for this specific group without interfering with their glaucoma treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tulane University Medical Center
New Orleans, Louisiana, 70112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.